Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...